Signal/NN
transducer/NN
and/CC
activator/NN
of/IN
transcription-3/NN
(/(
STAT3/NN
)/)
is/VBZ
constitutively/RB
activated/VBN
in/IN
normal/JJ
,/,
self-renewing/JJ
B-1/NN
cells/NNS
but/CC
only/RB
inducibly/RB
expressed/VBN
in/IN
conventional/JJ
B/NN
lymphocytes/NNS
[/(
see/VB
comments/NNS
]/)

Cytokine/NN
and/CC
growth/NN
factor/NN
receptor/NN
engagement/NN
leads/VBZ
to/TO
the/DT
rapid/JJ
phosphorylation/NN
and/CC
activation/NN
of/IN
latent/JJ
,/,
cytosolic/JJ
signal/NN
transducers/NNS
and/CC
activators/NNS
of/IN
transcription/NN
(/(
STAT/NN
)/)
proteins/NNS
,/,
which/WDT
then/RB
translocate/VBP
to/TO
the/DT
nucleus/NN
where/WRB
they/PRP
regulate/VBP
transcriptional/JJ
events/NNS
from/IN
specific/JJ
promoter/NN
sequences/NNS
./.
=====
STAT3/NN
expression/NN
in/IN
particular/JJ
has/VBZ
been/VBN
associated/VBN
with/IN
Abl/NN
,/,
Src/NN
,/,
and/CC
HTLV-1/NN
transformation/NN
of/IN
normal/JJ
cells/NNS
./.
=====
B-1/NN
lymphocytes/NNS
are/VBP
self-renewing/JJ
,/,
CD5+/JJ
B/NN
cells/NNS
that/WDT
display/VBP
a/DT
propensity/NN
for/IN
malignant/JJ
transformation/NN
and/CC
are/VBP
the/DT
normal/JJ
counterpart/NN
to/TO
human/JJ
chronic/JJ
lymphocytic/JJ
leukemias/NNS
./.
=====
Further/RB
,/,
B-1/NN
cells/NNS
are/VBP
characterized/VBN
by/IN
aberrant/JJ
intracellular/JJ
signaling/NN
,/,
including/VBG
hyperresponsiveness/NN
to/TO
phorbol/NN
ester/NN
PKC/NN
agonists/NNS
./.
=====
Here/RB
we/PRP
demonstrate/VBP
that/IN
B-1/NN
lymphocytes/NNS
constitutively/RB
express/VBP
nuclear/JJ
activated/VBN
STAT3/NN
,/,
which/WDT
is/VBZ
not/RB
expressed/VBN
by/IN
unmanipulated/JJ
conventional/JJ
(/(
B-2/NN
)/)
lymphocytes/NNS
./.
=====
In/IN
contrast/NN
,/,
STAT3/NN
activation/NN
is/VBZ
induced/VBN
in/IN
B-2/NN
cells/NNS
after/IN
antigen/NN
receptor/NN
engagement/NN
in/IN
a/DT
delayed/JJ
fashion/NN
(/(
after/IN
3/CD
h/NN
)/)
./.
=====
Induction/NN
of/IN
STAT3/NN
is/VBZ
inhibited/VBN
by/IN
both/CC
the/DT
serine/threonine/NN
protein/NN
kinase/NN
inhibitor/NN
H-7/NN
and/CC
the/DT
immunosuppressive/JJ
drug/NN
rapamycin/NN
and/CC
requires/VBZ
de/FW
novo/FW
protein/NN
synthesis/NN
,/,
demonstrating/VBG
novel/JJ
coupling/NN
between/IN
sIg/NN
and/CC
STAT/NN
proteins/NNS
that/WDT
differs/VBZ
from/IN
the/DT
classical/JJ
paradigm/NN
for/IN
STAT/NN
induction/NN
by/IN
cytokine/NN
receptors/NNS
./.
=====
The/DT
inability/NN
of/IN
prolonged/JJ
stimulation/NN
of/IN
conventional/JJ
B-2/NN
cells/NNS
with/IN
anti-Ig/NN
,/,
a/DT
treatment/NN
sufficient/JJ
to/TO
induce/VB
CD5/NN
expression/NN
,/,
to/TO
result/VB
in/IN
sustained/JJ
STAT3/NN
activation/NN
suggests/VBZ
that/IN
STAT3/NN
is/VBZ
a/DT
specific/JJ
nuclear/JJ
marker/NN
for/IN
B-1/NN
cells/NNS
./.
=====
Thus/RB
,/,
STAT3/NN
may/MD
play/VB
a/DT
role/NN
in/IN
B/NN
cell/NN
antigen-specific/JJ
signaling/NN
responses/NNS
,/,
and/CC
its/PRP$
constitutive/JJ
activation/NN
is/VBZ
associated/VBN
with/IN
a/DT
normal/JJ
cell/NN
population/NN
exhibiting/VBG
intrinsic/JJ
proliferative/JJ
behavior/NN
./.